OPTFSNA
GYRE icon

Old Point Trust & Financial Services N A’s Gyre Therapeutics GYRE Stock Holding History

Old Point Trust & Financial Services N A’s Portfolio GYRE Stock Details GYRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-33
Closed -$577 – 422
2024
Q1 		$577 Buy
+33
New +$595 ﹤0.01% 486

Other funds holding GYRE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
WG
Winton Group London, United Kingdom $2.85B AUM 30.73% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Old Point Trust & Financial Services N A's GYRE Position: Q2 2024 in Review

Old Point Trust & Financial Services N A sold out of Gyre Therapeutics (GYRE) in Q2 2024, closing a stake of 33 shares — an estimated $577 sold.

Old Point Trust & Financial Services N A first reported a position in GYRE in Q1 2024 and held it in 1 quarter. The position peaked at $577 in Q1 2024. 30 funds tracked by Wall St. Rank hold GYRE as of Q2 2024.

  • Old Point Trust & Financial Services N A reported no remaining Gyre Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Old Point Trust & Financial Services N A sold 33 Gyre Therapeutics shares in Q2 2024, an estimated $577.
  • Old Point Trust & Financial Services N A first reported a position in Gyre Therapeutics in Q1 2024 and held it in 1 quarter.
  • Old Point Trust & Financial Services N A's Gyre Therapeutics position peaked at $577 in Q1 2024.
  • 30 funds tracked by Wall St. Rank held Gyre Therapeutics as of Q2 2024.

Based on Old Point Trust & Financial Services N A's 13F filing for Q2 2024, filed 13 Aug 2024.